Product Information
CYPROHEPTADINE 2 MG/5 ML SOLN is a generic product labeled by Patrin Pharma Inc., priced at $0.0419 per ML under NDC 39328054416. Its NADAC has been published 186 times since Mar 15, 2023.
FDA first approved this application on Oct 16, 2018. Its Orange Book therapeutic-equivalence code is AA.
Strength
2 mg/5mL
Manufacturer
Patrin Pharma Inc.NDC
39328054416
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CYPROHEPTADINEApproval Type
Generic (ANDA)
FDA Application
ANDA209108FDA Approved
10/16/2018
TE Code
AA
On Market Since
2/15/2022
Price Statistics
The NADAC for CYPROHEPTADINE 2 MG/5 ML SOLN has been published 186 times since Mar 15, 2023, and over the history we have for it it has declined 17.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0419 per ML |
|---|---|
| All-time high | $0.0542 (Dec 13, 2023) |
| All-time low | $0.0377 (Jan 22, 2025) |
| 52-week high | $0.0423 |
| 52-week low | $0.0404 |
| Median price | $0.0421 |
| Average price | $0.0434 |
| Largest weekly change | +19.8% (Nov 22, 2023) |
| Weeks tracked | 186 |
| Tracking since | Mar 15, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Cyproheptadine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Patrin Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cyproheptadine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CYPROHEPTADINE 2 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for CYPROHEPTADINE 2 MG/5 ML SOLN, manufactured by Patrin Pharma Inc., is $0.0419 per ML (NDC 39328054416), effective Sep 30, 2026.
How has the price of CYPROHEPTADINE 2 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for CYPROHEPTADINE 2 MG/5 ML SOLN has declined 17.4%. It has been tracked across 186 weekly CMS publications since Mar 15, 2023.
What are the highest and lowest recorded NADAC prices for CYPROHEPTADINE 2 MG/5 ML SOLN?
Since Mar 15, 2023, the NADAC for CYPROHEPTADINE 2 MG/5 ML SOLN has ranged from a low of $0.0377 (Jan 22, 2025) to a high of $0.0542 (Dec 13, 2023), with a median of $0.0421 per ML.
Are there cheaper alternatives to CYPROHEPTADINE 2 MG/5 ML SOLN?
No other NADAC-published product currently shares the active ingredient and strength of CYPROHEPTADINE 2 MG/5 ML SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CYPROHEPTADINE 2 MG/5 ML SOLN?
CYPROHEPTADINE 2 MG/5 ML SOLN (NDC 39328054416) is labeled by Patrin Pharma Inc., and CMS classifies it as a generic product.